Literature DB >> 6456690

Biliary excretion of moxalactam.

O V Martinez, J U Levi, A Livingstone, T I Malinin, R Zeppa, D Hutson, N Einhorn.   

Abstract

The biliary excretion of moxalactam was studied in 11 postsurgery patients who had indwelling T-tubes inserted in their common bile ducts. Peak levels of moxalactam in the bile reached mean levels of 33.7 +/- 11.1 and 173.7 +/- 67.0 micrograms/ml 2 h after intravenous administration of a single 500- or 2,000-mg dose, respectively. In 5 of the 10 patients given the 2,000-mg dose, peak moxalactam concentrations in the bile were 2 to 12 times higher than simultaneous serum levels, but considerable variation in the biliary excretion of moxalactam was observed among the individual patients.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6456690      PMCID: PMC181668          DOI: 10.1128/AAC.20.2.231

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  17 in total

1.  Anaerobes in human biliary tracts.

Authors:  D M England; J E Rosenblatt
Journal:  J Clin Microbiol       Date:  1977-11       Impact factor: 5.948

2.  Biliary bacteriology based on intraoperative bile cultures.

Authors:  P G Delikaris; P O Michail; G D Klonis; N C Haritopoulos; B C Golematis; D A Dreiling
Journal:  Am J Gastroenterol       Date:  1977-07       Impact factor: 10.864

3.  Bacterial isolates in cholecystitis and cholelithiasis.

Authors:  T Bergan; I Dobloug; I Liavåg
Journal:  Scand J Gastroenterol       Date:  1979       Impact factor: 2.423

4.  Prophylactic use of cephazolin against wound sepsis after cholecystectomy.

Authors:  C J Strachan; J Black; S J Powis; T A Waterworth; R Wise; A R Wilkinson; D W Burdon; M Severn; B Mitra; H Norcott
Journal:  Br Med J       Date:  1977-05-14

5.  Bacteria and biliary tract disease.

Authors:  J T Goswitz
Journal:  Am J Surg       Date:  1974-11       Impact factor: 2.565

6.  Preoperative antibiotics in biliary surgery.

Authors:  S H Chetlin; D W Elliott
Journal:  Arch Surg       Date:  1973-08

7.  Biliary excretion and tissue levels of cefuroxime. A study in eleven patients undergoing cholecystectomy.

Authors:  M Severn; S J Powis
Journal:  J Antimicrob Chemother       Date:  1979-03       Impact factor: 5.790

8.  Biliary levels of cefoxitin.

Authors:  M N Logan; R Wise; R P Grimley
Journal:  J Antimicrob Chemother       Date:  1979-09       Impact factor: 5.790

9.  Excretion of cefamandole, cefazolin, and cephalothin into T-tube bile.

Authors:  K R Ratzan; H B Baker; I Lauredo
Journal:  Antimicrob Agents Chemother       Date:  1978-06       Impact factor: 5.191

10.  Cephalexin levels in human bile in presence of biliary tract disease.

Authors:  J E Sales; M Sutcliffe; F O'Grady
Journal:  Br Med J       Date:  1972-08-19
View more
  7 in total

1.  Single- and multiple-dose pharmacokinetics of moxalactam in normal subjects.

Authors:  K S Israel; H R Black; G L Brier; J D Wolny; K A DeSante
Journal:  Antimicrob Agents Chemother       Date:  1982-07       Impact factor: 5.191

2.  Moxalactam kinetics during continuous ambulatory peritoneal dialysis after intraperitoneal administration.

Authors:  T E Jones; R W Milne; Y Mudaliar; L N Sansom
Journal:  Antimicrob Agents Chemother       Date:  1985-08       Impact factor: 5.191

3.  Population Pharmacokinetics and Dosing Regimen Optimization of Latamoxef in Chinese Children.

Authors:  Yang Wang; Dan Sun; Yan Mei; Sanlan Wu; Xinlin Li; Sichan Li; Jun Wang; Liuliu Gao; Hua Xu; Yali Tuo
Journal:  Pharmaceutics       Date:  2022-05-11       Impact factor: 6.525

4.  Pharmacokinetics of moxalactam in elderly subjects.

Authors:  M H Andritz; R P Smith; A L Baltch; P E Griffin; J V Conroy; N Sutphen; M C Hammer
Journal:  Antimicrob Agents Chemother       Date:  1984-01       Impact factor: 5.191

5.  Biliary excretion of aztreonam in patients with biliary tract disease.

Authors:  O V Martinez; J U Levi; R G Devlin
Journal:  Antimicrob Agents Chemother       Date:  1984-03       Impact factor: 5.191

6.  High performance liquid chromatographic determination of moxalactam in human plasma and cerebrospinal fluid.

Authors:  J Nielsen; G Karlaganis; H M von Hattingberg; U B Schaad
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

7.  Steady-state moxalactam pharmacokinetics in patients: noncompartmental versus two-compartmental analysis.

Authors:  D J Swanson; D P Reitberg; I L Smith; P B Wels; J J Schentag
Journal:  J Pharmacokinet Biopharm       Date:  1983-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.